vs

Side-by-side financial comparison of FLEXSTEEL INDUSTRIES INC (FLXS) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

FLEXSTEEL INDUSTRIES INC is the larger business by last-quarter revenue ($115.1M vs $37.2M, roughly 3.1× Organogenesis Holdings Inc.). On growth, FLEXSTEEL INDUSTRIES INC posted the faster year-over-year revenue change (1.0% vs -57.1%). Over the past eight quarters, FLEXSTEEL INDUSTRIES INC's revenue compounded faster (1.9% CAGR vs -46.5%).

Flexsteel Industries Inc is a leading U.S.-headquartered furniture manufacturer that designs, produces and distributes a wide portfolio of upholstered residential, commercial, and hospitality furniture. It primarily operates across North American markets, serving end consumers, retail partners and corporate clients through its extensive distribution network.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

FLXS vs ORGO — Head-to-Head

Bigger by revenue
FLXS
FLXS
3.1× larger
FLXS
$115.1M
$37.2M
ORGO
Growing faster (revenue YoY)
FLXS
FLXS
+58.1% gap
FLXS
1.0%
-57.1%
ORGO
Faster 2-yr revenue CAGR
FLXS
FLXS
Annualised
FLXS
1.9%
-46.5%
ORGO

Income Statement — Q1 FY2027 vs Q1 FY2026

Metric
FLXS
FLXS
ORGO
ORGO
Revenue
$115.1M
$37.2M
Net Profit
$20.4M
Gross Margin
22.6%
30.8%
Operating Margin
-185.1%
Net Margin
17.7%
Revenue YoY
1.0%
-57.1%
Net Profit YoY
116.0%
EPS (diluted)
$1.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLXS
FLXS
ORGO
ORGO
Q3 26
$115.1M
Q1 26
$37.2M
Q4 25
$118.2M
$225.6M
Q3 25
$110.4M
$150.9M
Q2 25
$114.6M
$101.0M
Q1 25
$114.0M
$86.7M
Q4 24
$108.5M
$126.7M
Q3 24
$104.0M
$115.2M
Net Profit
FLXS
FLXS
ORGO
ORGO
Q3 26
$20.4M
Q1 26
Q4 25
$6.6M
$43.7M
Q3 25
$7.3M
$21.6M
Q2 25
$10.7M
$-9.4M
Q1 25
$-3.7M
$-18.8M
Q4 24
$9.1M
$7.7M
Q3 24
$4.1M
$12.3M
Gross Margin
FLXS
FLXS
ORGO
ORGO
Q3 26
22.6%
Q1 26
30.8%
Q4 25
22.7%
Q3 25
23.5%
Q2 25
23.9%
Q1 25
22.2%
72.6%
Q4 24
21.0%
75.5%
Q3 24
21.5%
76.7%
Operating Margin
FLXS
FLXS
ORGO
ORGO
Q3 26
Q1 26
-185.1%
Q4 25
7.6%
28.1%
Q3 25
8.1%
13.7%
Q2 25
12.2%
-12.5%
Q1 25
-4.4%
-30.9%
Q4 24
10.7%
8.1%
Q3 24
5.8%
5.4%
Net Margin
FLXS
FLXS
ORGO
ORGO
Q3 26
17.7%
Q1 26
Q4 25
5.6%
19.4%
Q3 25
6.6%
14.3%
Q2 25
9.3%
-9.3%
Q1 25
-3.3%
-21.7%
Q4 24
8.3%
6.1%
Q3 24
4.0%
10.7%
EPS (diluted)
FLXS
FLXS
ORGO
ORGO
Q3 26
$1.14
Q1 26
Q4 25
$1.18
$0.31
Q3 25
$1.31
$0.11
Q2 25
$1.90
$-0.10
Q1 25
$-0.71
$-0.17
Q4 24
$1.62
$0.05
Q3 24
$0.74
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLXS
FLXS
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$57.3M
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$185.3M
Total Assets
$290.2M
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLXS
FLXS
ORGO
ORGO
Q3 26
$57.3M
Q1 26
$91.4M
Q4 25
$36.8M
$93.7M
Q3 25
$38.6M
$63.7M
Q2 25
$40.0M
$73.1M
Q1 25
$22.6M
$110.0M
Q4 24
$11.8M
$135.6M
Q3 24
$5.7M
$94.3M
Total Debt
FLXS
FLXS
ORGO
ORGO
Q3 26
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Stockholders' Equity
FLXS
FLXS
ORGO
ORGO
Q3 26
$185.3M
Q1 26
Q4 25
$178.9M
$300.1M
Q3 25
$172.2M
$255.1M
Q2 25
$167.9M
$233.2M
Q1 25
$158.1M
$242.9M
Q4 24
$161.9M
$262.9M
Q3 24
$154.7M
$278.5M
Total Assets
FLXS
FLXS
ORGO
ORGO
Q3 26
$290.2M
Q1 26
$520.0M
Q4 25
$290.2M
$598.7M
Q3 25
$281.5M
$509.8M
Q2 25
$282.5M
$461.1M
Q1 25
$266.1M
$467.4M
Q4 24
$271.5M
$497.9M
Q3 24
$268.7M
$446.3M
Debt / Equity
FLXS
FLXS
ORGO
ORGO
Q3 26
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FLXS
FLXS
ORGO
ORGO
Operating Cash FlowLast quarter
$27.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.33×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FLXS
FLXS
ORGO
ORGO
Q3 26
$27.2M
Q1 26
Q4 25
$1.0M
$39.4M
Q3 25
$4.1M
$3.1M
Q2 25
$15.6M
$-32.9M
Q1 25
$12.3M
$-19.9M
Q4 24
$6.7M
$10.9M
Q3 24
$2.4M
$8.7M
Free Cash Flow
FLXS
FLXS
ORGO
ORGO
Q3 26
Q1 26
Q4 25
$-735.0K
$34.8M
Q3 25
$2.8M
$844.0K
Q2 25
$15.1M
$-36.5M
Q1 25
$10.9M
$-23.6M
Q4 24
$5.8M
$7.6M
Q3 24
$2.0M
$6.1M
FCF Margin
FLXS
FLXS
ORGO
ORGO
Q3 26
Q1 26
Q4 25
-0.6%
15.4%
Q3 25
2.5%
0.6%
Q2 25
13.1%
-36.1%
Q1 25
9.6%
-27.2%
Q4 24
5.3%
6.0%
Q3 24
1.9%
5.3%
Capex Intensity
FLXS
FLXS
ORGO
ORGO
Q3 26
Q1 26
Q4 25
1.5%
2.1%
Q3 25
1.2%
1.5%
Q2 25
0.5%
3.6%
Q1 25
1.2%
4.2%
Q4 24
0.8%
2.7%
Q3 24
0.4%
2.2%
Cash Conversion
FLXS
FLXS
ORGO
ORGO
Q3 26
1.33×
Q1 26
Q4 25
0.15×
0.90×
Q3 25
0.56×
0.14×
Q2 25
1.46×
Q1 25
Q4 24
0.74×
1.43×
Q3 24
0.58×
0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons